Article Types

Letters

Men's health Letters 4 November 2013 Free

The dilemmas of prostate cancer screening

Recent articles in the MJA reflect the continuing polarisation of the debate on prostate-specific antigen-based screening and the extent to which major clinical trials reveal whether lives are saved by intervention and/or watchful waiting.

George G Miklos

13 10851
Men's health Letters 4 November 2013 Free

The dilemmas of prostate cancer screening

To the Editor: We are concerned by conclusions drawn by Del Mar and colleagues,1 in stating that because some autopsy studies have claimed more than 50% prevalence of latent prostate cancer in men aged over 60 years, this could be considered normal, and that these latent cancers result in a high level of overdiagnosis of prostate cancer. The study cited was conducted at Wayne State University, ...

Paul R McKenzie · Brett Delahunt · James G Kench

Men's health Letters 4 November 2013 Free

The dilemmas of prostate cancer screening

To the Editor: Recent articles in the Journal evaluating the evidence on screening for early-stage prostate cancer1,2 failed to mention one of the most important pieces of evidence ever published on the treatment of prostate cancer.3 This randomised controlled trial (RCT) showed that, compared with observation, radical prostatectomy did not significantly reduce all-cause or prostate cancer mortality over at least 12 years among men with clinically ...

Ian E Haines

Men's health Letters 4 November 2013 Free

The dilemmas of prostate cancer screening

To the Editor: We read with interest Del Mar and colleagues’ “re-examination” of the evidence for prostate cancer screening.1 Rather than presenting a balanced view, they have pursued a lopsided and flawed review of the data. First, they have given equal weighting to the results of the screening trials from Europe (ERSPC [European Randomized Study of Screening for Prostate Cancer]) and North America (PLCO [Prostate, Lung, ...

Nathan Lawrentschuk · Declan G Murphy · Anthony J Costello

Men's health Letters 4 November 2013 Free

The dilemmas of prostate cancer screening

In reply: We wish to make some comments in response to Haines’s point that the PIVOT (Prostate Cancer Intervention Versus Observation Trial) failed to show any benefit from radical prostatectomy (RP) over surveillance. First, in the PIVOT, a benefit of RP in terms of reduced all-cause mortality was suggested in men with a prostate-specific antigen (PSA) level > 10 ng/mL and in men with intermediate- and high-risk prostate ...

Jonas Hugosson · Sigrid V Carlsson

Men's health Letters 4 November 2013 Free

The dilemmas of prostate cancer screening

In reply: We thank Lawrentschuk and colleagues for the critical response. We would like to respond to several wrong assertions: We did not give equal weighting to the results of the ERSPC (European Randomized Study of Screening for Prostate Cancer) and the PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial). Standard meta-analysis practice is to weight studies by the inverse variances of their effect estimates.1 ...

Chris B Del Mar*

Cancer Letters 4 November 2013 Free

Should we screen for lung cancer in Australia?

To the Editor: The United States National Lung Screening Trial demonstrated a 20% reduction in lung cancer deaths among smokers screened with three low-radiation-dose computed tomography scans at yearly intervals. Hew and colleagues recently outlined the challenges in implementing such a screening program in Australia.1 However, the potential for saving lives is enormous. Currently only 14.1% of lung cancer patients survive 5 years — a marginal improvement ...

Paul L R Mitchell · Thomas John

Cancer Letters 4 November 2013 Free

Should we screen for lung cancer in Australia?

In reply: We welcome the opportunity to respond to correspondence from Marshall and colleagues and Mitchell and colleagues about the impact of the National Lung Screening Trial (NLST)1 on three distinct issues: (i) current medical practice; (ii) developing public health policy; and (iii) implementation of future screening. Current medical practice: We do not currently recommend community screening. In the absence of resourced, educated, and coordinated referral ...

Mark Hew · Robert G Stirling · Michael J Abramson

Mental health Letters 21 October 2013 Free

Suicide risk assessment: where are we now?

In reply: It is not possible to usefully divide patients who present in psychological crisis into those at higher or lower risk of eventual suicide. Categorising patients in this way cannot assist in determining their management. Acknowledging this, Gordon and Melvin speculate that it might be possible to usefully divide such patients into those at higher or lower risk of eventual suicide attempt. That seems unlikely. ...

Christopher J Ryan · Matthew M Large · Sascha Callaghan

13 10840

Removing the GST exemption for fresh fruits and vegetables could cost lives

To the Editor: Since the Henry tax review recommended broadening the base of the goods and services tax (GST),2 there have been rumours that the current exemption for fresh foods, such as fruits and vegetables, might be removed.2 Changes in government are often accompanied by a review of policies, and broadening the tax base is appealing because it would increase efficiency and raise revenue. But ...

J Lennert Veerman · Linda J Cobiac

Letters 21 October 2013 Free

Updated Creutzfeldt–Jakob disease infection control guidelines: sifting facts from fiction

In reply: We thank Hodgson for sharing his concerns, affording us the opportunity to reassure the medical and non-medical communities about the utility of recently revised infection control guidelines for Creutzfeldt–Jakob disease (CJD).1 We reiterate that sporadic CJD is already endemic in Australia, necessitating guidelines that are regularly updated to ensure relevant scientific developments are incorporated, and that variant CJD (a zoonosis related to “mad ...

Steven J Collins · Eugene Athan · Ann P Koehler

13 10475
Infectious diseases Letters 16 October 2013 Free

Risk of measles transmission on aeroplanes: Australian experience 2007–2011

To the Editor: We thank Hoad and colleagues for presenting data from Australian states and territories regarding in-flight exposure to measles.1 The current cases in Queensland, Victoria and New South Wales, which have included domestic air travel,2 highlight the challenges measles still holds for Australia. Hoad et al’s report outlines the substantial public health response that such air travel events generate, despite the low likelihood of ...

Stephen B Lambert · Frank H Beard

Subscribe to MJA email alerts

No spam, you can unsubscribe anytime you want.

By providing your information, you agree to our Terms of Use and our Privacy Policy.

Thanks for Subscribing! Tell us more

Your email updates will use your name.

Good one! Your updates are coming

Thank you for subscribing to the MJA email alerts. Receive the latest content in your inbox.